AO | Jotup

SAIL Fusion Announces FDA Clearance of its BowTie™ Sacroiliac Fusion System

Retrieved on:

Tuesday, April 23, 2024

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, today announced that it has received FDA clearance for its novel BowTie Sacroiliac Fusion System.

Key Points:

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon proven AO principles, today announced that it has received FDA clearance for its novel BowTie Sacroiliac Fusion System.
The system will be launched to a select group of initial surgeons in preparation for a greater expansion in the coming months.
“There hasn’t been meaningful differentiation in the SI fusion market for many years,” remarked David Jansen, the President & CEO of SAIL.
Our approach challenges the prevailing trend of lateral fixation that is more appropriate for stabilization rather than true joint fusion.

M-tron Industries, Inc. Elevates Linda Biles to Executive Vice President

Retrieved on:

Tuesday, April 16, 2024

Engineering, Aerospace, Manufacturing, Executive, Controller, Canisius College, Management

M-tron Industries, Inc. (NYSE American: MPTI) (“Company” or “MtronPTI”) is delighted to announce the promotion of Linda Biles to the position of Executive Vice President of Finance, effective April 16, 2024.

Key Points:

M-tron Industries, Inc. (NYSE American: MPTI) (“Company” or “MtronPTI”) is delighted to announce the promotion of Linda Biles to the position of Executive Vice President of Finance, effective April 16, 2024.
Linda has demonstrated dedication, exceptional leadership, and outstanding financial acumen throughout her tenure at MtronPTI.
In Linda’s previous roll as Vice President & Controller, she has exhibited exceptional proficiency in managing financial operations, driving efficiencies, and fostering financial growth.
“We are thrilled to announce Linda’s promotion to the role of Executive Vice President of Finance,” said Michael Ferrantino, CEO.

Animal Biosciences Announces New Canine Clinical Research Evaluating Reversal of Age-Related Signs in Dogs

Retrieved on:

Tuesday, March 5, 2024

Animal Biosciences, Inc. , a company aiming to extend the lifespan of pets, today announced new clinical research published to the preprint server BioRxiv that tested the effects of their “LeapYears” supplement designed to extend healthspan in dogs.

Key Points:

Animal Biosciences, Inc. , a company aiming to extend the lifespan of pets, today announced new clinical research published to the preprint server BioRxiv that tested the effects of their “LeapYears” supplement designed to extend healthspan in dogs.
After five years of development and testing in dogs, leveraging discoveries made at Harvard Medical School, the study shows the first clinical evidence that it is possible to reverse age-related decline in dogs.
"The outcomes of the clinical trial, especially the enhancements in cognition, are encouraging and represent a unique achievement,” Dr. Olby noted.
In senior dogs, as in humans, this age-related decline can manifest as cognitive decline, increased frailty and lower engagement.

WOVEN ORTHOPEDICS SECURES SECOND FDA SPINE CLEARANCE - OGMEND® NOW AVAILABLE FOR MOST PEDICLE SCREW DIAMETERS

Retrieved on:

Thursday, February 29, 2024

Commercial director, FDA, Food, Surgeon, Sacrum, Journal, Publication, Telescopic sight

MANCHESTER, Conn., Feb. 29, 2024 /PRNewswire/ -- Woven Orthopedic Technologies, developer of Ogmend®, a simple implantable sleeve that quickly and easily secures stable screw fixation, has received its second 510(k) clearance from the Food and Drug Administration (FDA) for the use of Ogmend® Implant Enhancement System in spine surgery.

Key Points:

MANCHESTER, Conn., Feb. 29, 2024 /PRNewswire/ -- Woven Orthopedic Technologies, developer of Ogmend®, a simple implantable sleeve that quickly and easily secures stable screw fixation, has received its second 510(k) clearance from the Food and Drug Administration (FDA) for the use of Ogmend® Implant Enhancement System in spine surgery.
Prominent industry groups and publications, including AO, the Journal of Neurosurgery, and the International Spine Study Group, have reported the complexities encountered in spinal surgeries, particularly in the lower lumbar and sacral segments.
These areas are commonly stabilized with larger diameter screws given their larger bone structure and the greater forces endured.
The resulting stresses placed on these screws can create challenges for surgeons that call for the use of special techniques and tools.

Carbon Unveils Dental Lab Automation Tools with the Launch of its Revolutionary Automatic Operation Suite at Lab Day Chicago 2024

Retrieved on:

Friday, February 23, 2024

Automatic, M3, Lab, Entrepreneurship, Printing

REDWOOD CITY, Calif., Feb. 23, 2024 /PRNewswire/ -- Today at Lab Day Chicago, Carbon, a leading product development and manufacturing technology company, announced its Automatic Operation (AO) suite of solutions designed to transform the landscape of dental lab automation. The innovative suite of automation solutions is designed to specifically meet the needs of dental labs, setting a new standard in lab automation and efficiency. By integrating the AO suite into workflows, labs not only benefit from Carbon's unmatched efficiency and precision but also greatly reduce print turnover times and processing labor.

Key Points:

The innovative suite of automation solutions is designed to specifically meet the needs of dental labs, setting a new standard in lab automation and efficiency.
"The launch of our Automatic Operation suite marks a pivotal step on our journey to elevate the dental lab industry," said Phil DeSimone, CEO and Co-Founder.
Carbon's AO suite is a leap forward in advanced dental lab technology, emphasizing efficiency, reliability, and scalability.
For more information about Carbon's Automatic Operation Suite and its components, visit www.carbon3d.com or contact your local Carbon representative.

Revolutionary Speech Technology Company CAMB.AI Announces $4M Seed Round Led by Courtside Ventures, Ikemori Ventures, & Eisaburo Maeda

Retrieved on:

Tuesday, February 6, 2024

Led by Courtside Ventures, Ikemori Ventures, and Eisaburo Maeda, the investor group includes TRTL Ventures and Blue Star Innovation Partners.

Key Points:

Led by Courtside Ventures, Ikemori Ventures, and Eisaburo Maeda, the investor group includes TRTL Ventures and Blue Star Innovation Partners.
The funding will power CAMB.AI’s continued growth and progress seen since the company was founded in 2022.
Since then, CAMB.AI has broken several technological barriers with their MARS TTS and BOLI Translator, built from the ground up for voice localization.
This ensures that the translated content remains as powerful and engaging as the original, maintaining the speaker’s intended impact.

Revolutionary Speech Technology Company CAMB.AI Announces $4M Seed Round Led by Courtside Ventures

Retrieved on:

Tuesday, February 6, 2024

Led by Courtside Ventures, the investor group includes TRTL Ventures, Blue Star Innovation Partners, Ikemori Ventures, and Eisaburo Maeda.

Key Points:

Led by Courtside Ventures, the investor group includes TRTL Ventures, Blue Star Innovation Partners, Ikemori Ventures, and Eisaburo Maeda.
The funding will power CAMB.AI’s continued growth and progress seen since the company was founded in 2022.
Since then, CAMB.AI has broken several technological barriers with their MARS TTS and BOLI Translator, built from the ground up for voice localization.
“This technology is truly remarkable,” said Vasu Kulkarni, Partner at lead investor Courtside Ventures.

UAE-Based Revolutionary Speech Technology Company CAMB.AI Announces $4M Seed Round Led by Courtside Ventures

Retrieved on:

Tuesday, February 6, 2024

Led by Courtside Ventures, the investor group includes TRTL Ventures, Blue Star Innovation Partners, Ikemori Ventures, and Eisaburo Maeda.

Key Points:

Led by Courtside Ventures, the investor group includes TRTL Ventures, Blue Star Innovation Partners, Ikemori Ventures, and Eisaburo Maeda.
The funding will power CAMB.AI’s continued growth and progress seen since the company was founded in 2022.
Since then, CAMB.AI has broken several technological barriers with their MARS TTS and BOLI Translator, built from the ground up for voice localization.
“This technology is truly remarkable,” said Vasu Kulkarni, Partner at lead investor Courtside Ventures.

Porsche 963 of Porsche Penske Motorsport victorious after gripping 24 Hours of Daytona

Retrieved on:

Monday, January 29, 2024

7 Porsche 963 fielded by the Porsche Penske Motorsport factory team has won the 24 Hours of Daytona.

Key Points:

7 Porsche 963 fielded by the Porsche Penske Motorsport factory team has won the 24 Hours of Daytona.
“The entire Porsche Penske Motorsport works team and everyone at the development center in Weissach [Germany] have worked extremely hard to lay the foundations for this success.
Four Porsche 963, two from Porsche Penske Motorsport and two from our strong customer teams, made it through without any major technical problems – that’s quite a feat in itself.
Daytona was definitely worth the trip for us.”
“An amazing day for the entire Porsche Penske Motorsport organization,” said Roger Penske, Founder and Chairman of the Penske Corporation.

Matteson Capital and AO Partner to Build Tallest Building in U.S

Retrieved on:

Saturday, January 20, 2024

Dream Tower, Heart, LLP, Food, NBA, Collection, City, Consultant, Boardwalk, Thinkbox, Sport, OKC, Workforce, Thunder, Growth, Construction

ORANGE, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- Matteson Capital, a multifaceted real estate investment and development company operating since 2004, and AO, a leading full-service architecture firm with design expertise spanning the full commercial and multi-family real estate spectrum, announced today that they will request a variance from the City of Oklahoma City to increase the height for one of the towers in the already entitled development known as The Boardwalk at Bricktown. If approved, the height variance will make the structure the tallest building in the United States and currently fifth tallest in the world.

Key Points:

If approved, the height variance will make the structure the tallest building in the United States and currently fifth tallest in the world.
The symbolic height honors the year that Oklahoma was admitted as the 46th state of the United States.
“Oklahoma City is experiencing a significant period of growth and transformation, making it well-positioned to support large-scale projects like the one envisioned for Bricktown,” said Scot Matteson, CEO of Matteson Capital.
The public also voted to fund a $900 million bond to build the Thunder a new state of the art arena in the area.